HR-010 (Shanghai Hrain Biotechnology)

N/A

Report date: 2025/01/26 19:20:01

Base Information

Drug NameHR-010 (Shanghai Hrain Biotechnology)

Drug Alias Nameanti-CD70 CAR-T cell therapy (Shanghai Hrain Biotechnology)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionCD70 antigen modulators

TargetsCD70 antigen

Therapy Area/IndicationsKidney Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHrain Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHrain Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsKidney Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A